The expression of Bcl-2-targeting miRNAs was found to be decreased in MALT lymphomas and in diffuse large B-cell lymphoma (DLBCL) with higher expressions of Bcl-2 in stages 3 and 4 of both types of lymphomas. The gene discussed is BCL2; the disease is lymphoma.